Literature DB >> 1397007

Antagonism by beta-eudesmol of neostigmine-induced neuromuscular failure in mouse diaphragms.

L C Chiou1, C C Chang.   

Abstract

beta-Eudesmol, a sesquiterpenol extracted from a Chinese herb, Atractylodes lancea, at 10-80 microM, did not affect muscle action potentials, miniature and evoked endplate potentials and acetylcholine-induced depolarization in the presence or absence of neostigmine in mouse phrenic nerve-diaphragms. However, the tetanic fade, muscle fasciculation and twitch potentiation induced by neostigmine were effectively antagonized by 20 microM beta-eudesmol. When trains of pulses were applied to the nerve in the presence of neostigmine, beta-eudesmol reduced the incidence of explosive depolarization of the endplate from 95% to 35-67% of junctions, and shortened the duration when it occurred. Moreover, both the maximal and steady-state depolarizations during repetitive stimulation were reduced while the amplitudes of steady-state endplate potentials were increased. The results suggest that beta-eudesmol antagonized neostigmine-induced neuromuscular failure mainly by a presynaptic action to depress the regenerative release of acetylcholine during repetitive stimulation. The mechanism of antagonism is obviously not tubocurarine-like and it is unrelated to desensitization of acetylcholine channels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1397007     DOI: 10.1016/0014-2999(92)90361-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics.

Authors:  Kesara Na-Bangchang; Tullayakorn Plengsuriyakarn; Juntra Karbwang
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-14       Impact factor: 2.629

Review 2.  Atractylodis Rhizoma: A review of its traditional uses, phytochemistry, pharmacology, toxicology and quality control.

Authors:  Wen-Jin Zhang; Zhen-Yu Zhao; Li-Kun Chang; Ye Cao; Sheng Wang; Chuan-Zhi Kang; Hong-Yang Wang; Li Zhou; Lu-Qi Huang; Lan-Ping Guo
Journal:  J Ethnopharmacol       Date:  2020-09-28       Impact factor: 4.360

3.  Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of Atractylodes lancea.

Authors:  Kesara Na-Bangchang; Inthuorn Kulma; Tullayakorn Plengsuriyakarn; Thipaporn Tharavanij; Kanawut Kotawng; Anurak Chemung; Nadda Muhamad; Juntra Karbwang
Journal:  J Tradit Complement Med       Date:  2021-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.